| |
| |
|
| Insider
Information: |
Shkreli Martin |
| Relationship: |
10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,765,168 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$10,873,435 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,765,168 |
|
|
| Total
Value |
$10,873,435 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Travere Therapeutics, Inc |
TVTX |
Fmr Officer Dir 10% Sh... |
2014-11-21 |
1,765,168 |
2012-12-12 |
0 |
Premium* |
|
|
Humanigen Inc |
HGEN |
10% Owner |
2016-08-26 |
0 |
2015-11-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
60 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HGEN |
Humanigen Inc |
10% Owner |
– – • |
2015-11-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
414,085 |
|
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2012-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,531,920 |
2,531,920 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2012-12-17 |
4 |
B |
$7.69 |
$769 |
D/D |
100 |
2,532,020 |
3.15 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2012-12-26 |
4 |
B |
$3.55 |
$355 |
D/D |
100 |
2,532,120 |
3.15 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2013-02-12 |
4 |
B |
$3.57 |
$5,000 |
D/D |
1,400 |
2,533,520 |
3.15 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2013-02-20 |
4 |
B |
$4.16 |
$4,662 |
D/D |
1,120 |
2,654,640 |
3.15 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2013-03-04 |
4 |
B |
$4.43 |
$4,425 |
D/D |
1,000 |
2,655,640 |
3.15 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2013-03-06 |
4 |
B |
$4.25 |
$425 |
D/D |
100 |
2,655,740 |
3.15 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2013-03-11 |
4 |
B |
$4.70 |
$1,880 |
D/D |
400 |
2,656,140 |
3.15 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2013-08-21 |
4 |
B |
$6.08 |
$17,024 |
D/D |
2,800 |
2,658,940 |
3.15 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2013-08-22 |
4 |
B |
$6.02 |
$6,622 |
D/D |
1,100 |
2,660,040 |
3.15 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2013-09-12 |
4 |
B |
$4.50 |
$50,004 |
D/D |
11,112 |
2,671,152 |
3.23 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2013-11-22 |
4 |
B |
$6.06 |
$1,818 |
D/D |
300 |
2,665,896 |
3.15 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2013-11-26 |
4 |
B |
$6.81 |
$1,021 |
D/D |
150 |
2,666,046 |
3.15 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2013-12-06 |
4 |
B |
$8.30 |
$830 |
D/D |
100 |
2,666,146 |
3.15 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2013-12-09 |
4 |
B |
$8.11 |
$811 |
D/D |
100 |
2,666,246 |
3.15 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2013-12-31 |
4 |
B |
$7.00 |
$1,050,000 |
D/D |
150,000 |
2,816,246 |
3.23 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2014-01-14 |
4 |
B |
$10.84 |
$86,694 |
D/D |
8,000 |
2,830,022 |
3.23 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2014-02-06 |
4 |
B |
$9.92 |
$19,832 |
D/D |
2,000 |
2,832,022 |
3.15 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2014-02-14 |
4 |
B |
$14.60 |
$51,106 |
D/D |
3,500 |
2,835,522 |
3.23 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2014-02-21 |
4 |
B |
$17.56 |
$28,102 |
D/D |
1,600 |
2,837,122 |
3.23 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2014-02-21 |
4 |
B |
$17.20 |
$1,720 |
D/D |
100 |
2,837,222 |
3.15 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2014-02-28 |
4 |
B |
$18.67 |
$802,677 |
D/D |
43,000 |
2,880,222 |
3.23 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2014-03-05 |
4 |
B |
$18.48 |
$73,906 |
D/D |
4,000 |
2,884,222 |
3.23 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2014-03-06 |
4 |
B |
$18.93 |
$29,528 |
D/D |
1,560 |
2,885,782 |
3.23 |
- |
|
60 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
